My top 10 things to watch Thursday, March 7 Stocks are set to open higher Thursday, looking to build off Wednesday’s gains. Wall Street began the week with back-to-back losing sessions. Fed chief Jerome Powell’s second day of congressional testimony, this time before the Senate Banking Committee, is scheduled to kick off a little after Thursday’s opening bell. Powell on Wednesday told lawmakers in the House that the Fed expects to cut interest rates later this year, but is not sure when the first one would be. New York Community Bancorp gets a $1 billion capital raise from several investment firms including Steven Mnuchin’s Liberty Strategic Capital. NYCB shares have been all over the place recently. Down more than 65% this year on concerns over exposure to commercial real estate. Not only Trump’s Treasury secretary, Mnuchin in 2009 led a group that bought a California bank out of receivership, turned it around, and sold it six years later. An early trial of Novo Nordisk ‘s next-generation obesity pill amycretin demonstrated significant weight loss in patients after 12 weeks. Shares of the Danish drugmaker, which is behind Ozempic for diabetes and Wegovy for obesity, jump more than 5% in premarket trading . For the Club, we own rival Eli Lilly as a weight-loss drug play. Lilly shares were down about 0.6% early Thursday. Mizuho boosts its price target on a host of chip stocks including Club holdings Nvidia and Broadcom . The firm goes to $1,000 a share from $850 on Nvidia and $1,550 from $1,450 on Broadcom, which reports after the close Thursday. Analysts said they expect earnings multiples to keep expanding during the artificial intelligence-fueled rally. Mizuho also hikes its price target for Bullpen name Advanced Micro Devices to $235 per share from $200 and keeps buy rating. The analysts cite the “continually” expanding AI chip market and see further multiple expansion, as with Nvidia and Broadcom. It looks like CrowdStrike is the winner for now in the…
Read the full article here
